Combining nitric oxide release with anti-inflammatory activity preserves nigrostriatal dopaminergic innervation and prevents motor impairment in a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease.
about
Insights into Neuroinflammation in Parkinson's Disease: From Biomarkers to Anti-Inflammatory Based TherapiesUncovering novel actors in astrocyte-neuron crosstalk in Parkinson's disease: the Wnt/β-catenin signaling cascade as the common final pathway for neuroprotection and self-repairAre cyclooxygenase-2 and nitric oxide involved in the dyskinesia of Parkinson's disease induced by L-DOPA?Targeting Wnt signaling at the neuroimmune interface for dopaminergic neuroprotection/repair in Parkinson's disease.Features of microglia and neuroinflammation relevant to environmental exposure and neurotoxicity.Proteomic Analysis of the Effect of Korean Red Ginseng in the Striatum of a Parkinson's Disease Mouse Model.Plasticity of subventricular zone neuroprogenitors in MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) mouse model of Parkinson's disease involves cross talk between inflammatory and Wnt/β-catenin signaling pathways: functional consequences for nAging-induced Nrf2-ARE pathway disruption in the subventricular zone drives neurogenic impairment in parkinsonian mice via PI3K-Wnt/β-catenin dysregulation.Clozapine metabolites protect dopaminergic neurons through inhibition of microglial NADPH oxidase.NADPH oxidase and neurodegenerationThe interplay between iron accumulation, mitochondrial dysfunction, and inflammation during the execution step of neurodegenerative disorders.l-DOPA-induced dyskinesia in Parkinson's disease: Are neuroinflammation and astrocytes key elements?Upregulation of autophagy-related gene 5 protects dopaminergic neurons in a zebrafish model of Parkinson's disease.Effect of Quercetin in the 1-Methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine-Induced Mouse Model of Parkinson's Disease.Metalloproteinase-9 contributes to inflammatory glia activation and nigro-striatal pathway degeneration in both mouse and monkey models of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced Parkinsonism.Sodium salicylate protects against rotenone-induced parkinsonism in rats.N-methyl N-nitrosourea induced functional and structural alterations in mice brain-role of curcumin.Microglia Polarization, Gene-Environment Interactions and Wnt/β-Catenin Signaling: Emerging Roles of Glia-Neuron and Glia-Stem/Neuroprogenitor Crosstalk for Dopaminergic Neurorestoration in Aged Parkinsonian Brain.Indomethacin promotes survival of new neurons in the adult murine hippocampus accompanied by anti-inflammatory effects following MPTP-induced dopamine depletion.Proteomic change by Korean Red Ginseng in the substantia nigra of a Parkinson's disease mouse modelStomaching the Possibility of a Pathogenic Role for Helicobacter pylori in Parkinson's Disease
P2860
Q26795984-01B1DF3D-2A9F-4363-B295-8210740977D5Q26865502-69FCACC0-B6D0-4047-ACD5-1A4A06AAB9C4Q27324133-8BFF6209-6E07-4327-A566-105F3A8E0E3EQ33771694-CD828BAD-66C1-4C91-A365-B59EA4CE0CBFQ35162073-E3FF6386-36AA-4D0E-9CD2-D0DFD339037CQ36176121-BBB6ED77-4468-4CCF-8F5A-35C11CF48633Q36566007-970ECCCD-A7D9-4D19-B509-9B8FA33007AFQ36587894-D353A82C-B4B5-4D1C-B91F-429E5FCD4DD6Q36907446-72EE464A-91D2-4ED7-AB1C-B3C26012E933Q38111373-C1A80F57-D738-4435-84A3-018644EA55DEQ38198015-4DA588F1-B1F7-49DE-BD2C-86C8AAEAE9CAQ38951947-59D72267-5E45-4367-9956-5F8A8CAB0AFAQ41996328-8B0D8B71-06F7-4BEC-A863-D63D41BDE9AEQ42227324-CB07089F-B6D3-42D4-A26C-5E5AC1A3C01FQ46929091-7CA6B0B0-5005-49A9-B22C-7ACBB5D36C13Q48145970-15FFDD3D-1BC8-41B9-BB4B-2C22B792309BQ48712152-73332708-D84A-4596-BE74-2157BE1A1410Q51767077-71297A87-4CDE-4C9B-A619-6A821A021A29Q55216971-22FA743E-5076-42C0-A7DE-58FEAA4A0EBCQ58595447-B9EB8E72-005C-489C-B88A-974C2CCC474AQ58779935-9D284CB0-771E-4BE8-9E19-2EC9FF587717
P2860
Combining nitric oxide release with anti-inflammatory activity preserves nigrostriatal dopaminergic innervation and prevents motor impairment in a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Combining nitric oxide release ...... model of Parkinson's disease.
@en
type
label
Combining nitric oxide release ...... model of Parkinson's disease.
@en
prefLabel
Combining nitric oxide release ...... model of Parkinson's disease.
@en
P2093
P2860
P356
P1476
Combining nitric oxide release ...... model of Parkinson's disease.
@en
P2093
Bianca Marchetti
Cataldo Tirolo
Francesca L'Episcopo
Francesco Impagnatiello
Maria C Morale
Nunzio Testa
Pier A Serra
Salvatore Caniglia
P2860
P2888
P356
10.1186/1742-2094-7-83
P577
2010-11-23T00:00:00Z
P5875
P6179
1008814045